CFSAN Adverse Event Strategy: Will Notifying Industry Create A 2-Way Road?
This article was originally published in The Tan Sheet
Executive Summary
CFSAN will begin sending letters to companies notifying them when an adverse event report involving one of their products has been received on or after Sept. 16
You may also be interested in...
Trans Fat Labeling Should Help Product Comparisons, FDAer Claims
FDA will conduct an "educational campaign" over the next couple of years to teach consumers about trans fat and what to consider when buying products that contain the substance, according to San Francisco District Office Public Affairs Specialist Janet McDonald, PhD
Trans Fat Labeling Should Help Product Comparisons, FDAer Claims
FDA will conduct an "educational campaign" over the next couple of years to teach consumers about trans fat and what to consider when buying products that contain the substance, according to San Francisco District Office Public Affairs Specialist Janet McDonald, PhD
Trans Fat Labeling Should Help Product Comparisons, FDAer Claims
FDA will conduct an "educational campaign" over the next couple of years to teach consumers about trans fat and what to consider when buying products that contain the substance, according to San Francisco District Office Public Affairs Specialist Janet McDonald, PhD